Search

everythinglearnresearchcommunity

for

Search:↓

Children under 10 can experience hair thinning without hormone issues, and it may improve with treatment.

Women with Polycystic Ovary Syndrome are more likely to have Non-Alcoholic Fatty Pancreas Disease, which is associated with older age, metabolic syndrome, insulin resistance, and high male hormone levels.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

Ultrasound measurement of the ovarian stroma to total area ratio is not a reliable single predictor of high male hormone levels in Thai women with PCOS, but works better when combined with clinical signs.

Different PCOS characteristics affect lipid profiles, increasing cardiovascular disease risk, so regular lipid screening is advised.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Women with PCOS often have mood disorders and a lower quality of life, and treatment should focus on both physical and mental health.

Hair loss in postmenopausal woman caused by ovarian issue.

Indian women with PCOS from Delhi and Srinagar show different symptoms, with Delhi women having higher obesity and blood sugar issues, and Srinagar women showing more hair growth and testosterone levels.

Myo-inositol and D-chiro-inositol, especially in a 40:1 ratio, effectively treat PCOS by improving insulin sensitivity and ovulation.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Testosterone therapy in transgender individuals can increase the risk of erythrocytosis.

Accurate diagnosis of hyperandrogenism, especially PCOS, is crucial for managing fertility and metabolic risks in women.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Metformin, a diabetes drug, may also help fight cancer, but more research is needed to understand how.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

Idiopathic hirsutism is the most common cause of hirsutism in women, followed by PCOS.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

The main cause of hirsutism in Algerian women is polycystic ovary syndrome, and those affected should be checked for related hormonal issues.

Spironolactone effectively reduces symptoms of hyperandrogenism like hirsutism and acne.

The document concludes that managing PCOS involves treating symptoms and reducing long-term metabolic risks, with lifestyle changes being important.

Ovarian Leydig cell tumors are hard to diagnose with just advanced imaging; expert ultrasound and clinical evaluation are essential.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

Adrenal disorders often cause high blood pressure in young people.

The virus was not found in the semen and urine of a man who tested positive for COVID-19.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Neurosteroids show promise for treating epilepsy and more research is needed.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.